A consortium of investors has sold AlgoNomics N.V., a Belgium-based biotechnology company that provides structural bioinformatics services to develop rationally designed therapeutics in the field of immunotherapy, to Lonza Group, Ltd.

Lonza is a Switzerland-based supplier of pharmaceutical active ingredients to the pharmaceutical, healthcare, and life science industries.